Baird Financial Group’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.11M | Buy |
143,292
+2,182
| +2% | +$97.5K | 0.01% | 732 |
|
|
2026
Q1 | $6.8M | Buy |
141,110
+7,163
| +5% | +$334K | 0.01% | 656 |
|
|
2025
Q4 | $6.49M | Sell |
133,947
-31,736
| -19% | -$1.57M | 0.01% | 663 |
|
|
2025
Q3 | $7.82M | Buy |
165,683
+5,951
| +4% | +$287K | 0.01% | 605 |
|
|
2025
Q2 | $7.72M | Sell |
159,732
-4,429
| -3% | -$226K | 0.01% | 582 |
|
|
2025
Q1 | $9.1M | Buy |
164,161
+21,121
| +15% | +$1.14M | 0.02% | 531 |
|
|
2024
Q4 | $6.9M | Sell |
143,040
-1,061
| -0.7% | -$53.9K | 0.01% | 590 |
|
|
2024
Q3 | $8.3M | Buy |
144,101
+10,355
| +8% | +$559K | 0.02% | 558 |
|
|
2024
Q2 | $6.49M | Buy |
133,746
+9,653
| +8% | +$466K | 0.01% | 599 |
|
|
2024
Q1 | $6.03M | Buy |
124,093
+13,852
| +13% | +$676K | 0.01% | 618 |
|
|
2023
Q4 | $5.48M | Sell |
110,241
-11,175
| -9% | -$546K | 0.01% | 639 |
|
|
2023
Q3 | $6.51M | Buy |
121,416
+28,877
| +31% | +$1.54M | 0.02% | 546 |
|
|
2023
Q2 | $4.99M | Buy |
92,539
+1,890
| +2% | +$102K | 0.01% | 625 |
|
|
2023
Q1 | $4.93M | Buy |
90,649
+7,538
| +9% | +$367K | 0.01% | 597 |
|
|
2022
Q4 | $4.03M | Sell |
83,111
-667
| -0.8% | -$29.3K | 0.01% | 638 |
|
|
2022
Q3 | $3.19M | Sell |
83,778
-67,781
| -45% | -$3.02M | 0.01% | 682 |
|
|
2022
Q2 | $7.58M | Buy |
151,559
+82,194
| +118% | +$4.36M | 0.02% | 493 |
|
|
2022
Q1 | $3.56M | Sell |
69,365
-912
| -1% | -$47.1K | 0.01% | 702 |
|
|
2021
Q4 | $3.52M | Buy |
70,277
+5,714
| +9% | +$283K | 0.01% | 726 |
|
|
2021
Q3 | $3.11M | Buy |
64,563
+3,812
| +6% | +$194K | 0.01% | 763 |
|
|
2021
Q2 | $3.2M | Buy |
60,751
+1,622
| +3% | +$84.6K | 0.01% | 742 |
|
|
2021
Q1 | $2.92M | Sell |
59,129
-5,940
| -9% | -$285K | 0.01% | 746 |
|
|
2020
Q4 | $3.16M | Sell |
65,069
-886
| -1% | -$43.7K | 0.01% | 671 |
|
|
2020
Q3 | $3.31M | Sell |
65,955
-10,245
| -13% | -$527K | 0.01% | 606 |
|
|
2020
Q2 | $3.89M | Sell |
76,200
-23,632
| -24% | -$1.15M | 0.01% | 538 |
|
|
2020
Q1 | $4.37M | Buy |
99,832
+9,677
| +11% | +$463K | 0.02% | 472 |
|
|
2019
Q4 | $4.53M | Sell |
90,155
-143,219
| -61% | -$6.71M | 0.02% | 553 |
|
|
2019
Q3 | $10.8M | Sell |
233,374
-12,130
| -5% | -$523K | 0.04% | 340 |
|
|
2019
Q2 | $10.6M | Sell |
245,504
-1,473
| -0.6% | -$62.6K | 0.04% | 347 |
|
|
2019
Q1 | $10.9M | Sell |
246,977
-7,119
| -3% | -$305K | 0.06% | 306 |
|
|
2018
Q4 | $11M | Buy |
254,096
+14,028
| +6% | +$619K | 0.07% | 275 |
|
|
2018
Q3 | $10.8M | Sell |
240,068
-4,536
| -2% | -$194K | 0.07% | 292 |
|
|
2018
Q2 | $9.79M | Sell |
244,604
-1,154
| -0.5% | -$45.4K | 0.07% | 297 |
|
|
2018
Q1 | $9.85M | Sell |
245,758
-36,777
| -13% | -$1.53M | 0.07% | 290 |
|
|
2017
Q4 | $12.1M | Sell |
282,535
-5,896
| -2% | -$272K | 0.09% | 245 |
|
|
2017
Q3 | $14.4M | Sell |
288,431
-58,023
| -17% | -$2.81M | 0.11% | 213 |
|
|
2017
Q2 | $16.6M | Sell |
346,454
-69,630
| -17% | -$3.33M | 0.13% | 198 |
|
|
2017
Q1 | $18.8M | Sell |
416,084
-329,243
| -44% | -$14M | 0.15% | 171 |
|
|
2016
Q4 | $30.1M | Sell |
745,327
-202,032
| -21% | -$7.96M | 0.26% | 118 |
|
|
2016
Q3 | $36.2M | Buy |
947,359
+129,156
| +16% | +$5.18M | 0.32% | 89 |
|
|
2016
Q2 | $34.3M | Buy |
818,203
+100,657
| +14% | +$4.13M | 0.31% | 88 |
|
|
2016
Q1 | $28.8M | Sell |
717,546
-4,488
| -0.6% | -$180K | 0.28% | 108 |
|
|
2015
Q4 | $30.8M | Sell |
722,034
-406,923
| -36% | -$18.7M | 0.31% | 92 |
|
|
2015
Q3 | $53.6M | Buy |
1,128,957
+7,281
| +0.6% | +$371K | 0.57% | 33 |
|
|
2015
Q2 | $55.6M | Buy |
+1,121,676
| New | +$56.8M | 0.55% | 33 |
|
Other funds holding SNY
MIP
BIP
Baird Financial Group's SNY Position: Q2 2026 in Review
Baird Financial Group increased its Sanofi (SNY) stake by 1.5% in Q2 2026, buying an estimated $97.5K and bringing the position to 143,292 shares worth $6.11M. The position accounts for 0.01% of the portfolio, ranked #732.
Baird Financial Group first reported a position in SNY in Q2 2015 and has held it in 45 quarters since. The position peaked at $55.6M in Q2 2015. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.
- Baird Financial Group held 143,292 shares of Sanofi worth $6.11M as of Q2 2026.
- Baird Financial Group bought 2,182 Sanofi shares in Q2 2026, an estimated $97.5K.
- Sanofi made up 0.01% of Baird Financial Group's portfolio in Q2 2026, its #732 holding.
- Baird Financial Group first reported a position in Sanofi in Q2 2015 and has held it in 45 quarters since.
- Baird Financial Group's Sanofi position peaked at $55.6M in Q2 2015.
- 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.
Based on Baird Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.